Effects of the Topical OLEOZON®, Ketoconazole and Terbinafine on Skin Lesions and Dermatophytes in Patients with Epidermophitosis
Advances in Clinical Pharmacology and Therapeutics · 03.09.2025 · 2 (2) · 29-38
DOI: 10.63623/4s39r825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Pharmacology and Therapeutics, online erschienen am 03.09.2025. Verfasst von Julio César Fernández Travieso und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dermatophytoses are fungal infections that are frequently diagnose all over the world. Dermatophytes are keratinophilic filamentous fungi that damage nails, skin, and hair. Treatment for dermatophytosis can be topical (creams, lotions, or ointments, such as ketoconazole and terbinafine) or systemic. Topical OLEOZON® (ozonated sunflower oil) is registered in Cuba for the treatment of Epidermophytosis. The aims of this post-hoc analysis was to evaluate and compare, for the first time, the effects of topical OLEOZON® versus ketoconazole and terbinafine on skin lesions and dermatophyte clearance in cuban patients with Epidermophytosis. The present analysis was obtained from the data of patients included in a previous Phase III comparative study. Efficacy variables include significant reduction in skin lesions and presence of dermatophytes. Statistical analysis was performed using the intention-to-treat approach. Three hundred patients of both sexes with a diagnosis of Epidermophytosis, were randomly assigned to receive topical OLEOZON®, or ketoconazole, or terbinafine. At the six weeks, all treatments significantly reduced all skin lesions and the presence of dermatophytes. However, there were no significant differences between groups in the comparisons made. The treatments were safe and well tolerated. It is concluded that topical OLEOZON® showed comparable effects to ketoconazole and terbinafine in reducing all skin lesions and the presence of dermatophytes in Cuban patients with Epidermophytosis, with a favorable impact on the clinical and mycological cure rate of these patients. These findings support the potential utility of OLEOZON® as an affordable, well-tolerated alternative in settings where conventional antifungal options may be limited or contraindicated.
Zitieren
APA
Travieso, J. C. F., Pla, E. A. G., Pérez, L. A., Liriano, Y. G., Wong, E. S., Ordaz, M. R., Cardoso, J. A. D., Sori, A. B., Carballo, A. L., Nuñez, Y. R., Domínguez, Y. F., Hernández, M. E. C., & Piña, R. U. (2025). Effects of the Topical OLEOZON®, Ketoconazole and Terbinafine on Skin Lesions and Dermatophytes in Patients with Epidermophitosis. Advances in Clinical Pharmacology and Therapeutics, 2(2), 29-38. https://doi.org/10.63623/4s39r825
Vancouver
Travieso JCF, Pla EAG, Pérez LA, Liriano YG, Wong ES, Ordaz MR, et al. Effects of the Topical OLEOZON®, Ketoconazole and Terbinafine on Skin Lesions and Dermatophytes in Patients with Epidermophitosis. Advances in Clinical Pharmacology and Therapeutics. 2025;2(2):29-38. doi:10.63623/4s39r825
BibTeX
@article{Travieso2025,
author = {Travieso, Julio César Fernández and Pla, Evelyn Anie González and Pérez, Lazara Alacán and Liriano, Yeni González and Wong, Elizabeth Sanler and Ordaz, Maylen Rodríguez and Cardoso, José Alejandro Díaz and Sori, Ada Bermúdez and Carballo, Ana Labrada and Nuñez, Yenney Reyes and Domínguez, Yanay Fernández and Hernández, Manuel Eduardo Cordero and Piña, Rolando Uranga},
title = {Effects of the Topical OLEOZON®, Ketoconazole and Terbinafine on Skin Lesions and Dermatophytes in Patients with Epidermophitosis},
journal = {Advances in Clinical Pharmacology and Therapeutics},
year = {2025},
volume = {2},
number = {2},
pages = {29--38},
doi = {10.63623/4s39r825}
}
EUVIMED